## **Core Concept**
Hemophilia A is a genetic disorder characterized by the deficiency of **factor VIII**, a crucial protein for blood coagulation. The severity of hemophilia A is directly correlated with the plasma levels of factor VIII. Recurrent spontaneous hemorrhosis, which refers to repeated episodes of bleeding into joints or muscles without any apparent cause, is a hallmark of severe hemophilia.

## **Why the Correct Answer is Right**
Patients with severe hemophilia A have factor VIII levels less than **1%** of normal. At these low levels, the coagulation cascade is significantly impaired, leading to an increased risk of spontaneous bleeding into joints (hemarthrosis) or muscles. This is because factor VIII plays a critical role in the intrinsic pathway of blood coagulation, acting as a cofactor for factor IXa in the activation of factor X. Without sufficient factor VIII, the formation of blood clots is severely compromised.

## **Why Each Wrong Option is Incorrect**
- **Option A:** > 40% - This level is considered mild hemophilia, and patients typically do not experience spontaneous hemorrhosis.
- **Option B:** 1-40% - This range corresponds to moderate hemophilia. While patients may experience some bleeding episodes, recurrent spontaneous hemorrhosis is less common compared to those with severe hemophilia.
- **Option D:** 10-20% - This is also within the moderate range and does not accurately reflect the level at which recurrent spontaneous hemorrhosis commonly occurs.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the risk of recurrent spontaneous hemorrhosis significantly increases when factor VIII levels fall below **1%**. Patients with severe hemophilia A (factor VIII < 1%) often require prophylactic factor VIII replacement therapy to prevent such episodes. ## **Correct Answer:** . **< 1%**